His scientific interests lie mostly in Antibody, Molecular biology, Complement system, Biochemistry and Immunology. His Antibody research includes themes of Plasma protein binding, Cyanogen bromide and Cytolysis. His Molecular biology research is multidisciplinary, incorporating elements of Virology, Epstein–Barr virus, Pathology, Complement C3d and Heparinase.
The various areas that he examines in his Complement system study include Cytokine and Cell biology. His Macromolecular Substances, Amino acid and Incubation study in the realm of Biochemistry connects with subjects such as Molecule and Diffusion. His Immunology research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Amyloid beta and Degenerative disease.
His main research concerns Molecular biology, Complement system, Antibody, Biochemistry and Immunology. His Molecular biology research incorporates elements of Antiserum, Epstein–Barr virus, Complement C3d, Epitope and Monoclonal antibody. The Antibody study combines topics in areas such as Virology, Immune system, Antigen, Cytolysis and Lysis.
His Biochemistry research incorporates themes from Complement C1s and Calcium. His Immunology study which covers Amyloid that intersects with Alzheimer's disease. His work deals with themes such as Neuroscience and Cytokine, which intersect with Inflammation.
Neil R. Cooper mainly investigates Immunology, Complement system, Cell biology, Inflammation and Molecular biology. His Microglia, Human b cell, Immune system and Hemolysis study, which is part of a larger body of work in Immunology, is frequently linked to CD23, bridging the gap between disciplines. His work in the fields of Classical complement pathway and Complement membrane attack complex overlaps with other areas such as In situ hybridization.
His Inflammation research is multidisciplinary, relying on both Cell culture, Cytokine, Disease, Amyloid and Neuroscience. His studies in Neuroscience integrate themes in fields like Amyloid beta, Acute-phase protein and Pathogenesis. His research investigates the connection with Molecular biology and areas like Epstein–Barr virus which intersect with concerns in CD19.
The scientist’s investigation covers issues in Cell biology, Complement system, Alzheimer's disease, Molecular biology and Neuroscience. He has included themes like Hippocampal formation, Receptor and Beta-peptide in his Cell biology study. His study of Classical complement pathway is a part of Complement system.
The study incorporates disciplines such as NF-κB, Signal transduction and Complement receptor in addition to Molecular biology. His Neuroscience research integrates issues from Inflammation, Amyloid beta and Cytokine. Neil R. Cooper interconnects Tau protein, Pathogenesis, Microglia, Cell activation and Neuroinflammation in the investigation of issues within Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inflammation and Alzheimer's disease.
H Akiyama;S Barger;S Barnum;B Bradt.
Neurobiology of Aging (2000)
Complement activation by beta-amyloid in Alzheimer disease
J Rogers;N R Cooper;S Webster;J Schultz.
Proceedings of the National Academy of Sciences of the United States of America (1992)
The classical complement pathway: activation and regulation of the first complement component.
Neil R. Cooper.
Advances in Immunology (1985)
Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.
Teresa Compton;Dawn M. Nowlin;Neil R. Cooper.
Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
G R Nemerow;C Mold;V K Schwend;V Tollefson.
Journal of Virology (1987)
Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
G R Nemerow;R Wolfert;M E McNaughton;N R Cooper.
Journal of Virology (1985)
Purification and radiolabeling of human C1q.
A J Tenner;P H Lesavre;N R Cooper.
Journal of Immunology (1981)
Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease
S Webster;L.-F Lue;L Brachova;A.J Tenner.
Neurobiology of Aging (1997)
Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bonnie M. Bradt;William P. Kolb;Neil R. Cooper.
Journal of Experimental Medicine (1998)
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
Neil R. Cooper;Fred C. Jensen;Raymond M. Welsh;Michael B. A. Oldstone.
Journal of Experimental Medicine (1976)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: